← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2006Last known activity
Nov 30, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (15 distinct, 12 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Recent trials (21)
- NCT06100510Study directorPhase 4Nov 30, 2023
- NCT05440968Overall official - principal investigatorN/AJun 30, 2022
- NCT05440968OfficialN/AJun 30, 2022
- NCT04530539Overall official - principal investigatorN/ASep 18, 2020
- NCT04529512Overall official - principal investigatorPhase 4Aug 31, 2020
- NCT04205916Overall official - principal investigatorPhase 4Nov 4, 2019
- NCT04130464Overall official - principal investigatorPhase 4Sep 30, 2019
- NCT03832179Reponsible party - principal investigatorPhase 4Nov 15, 2018
- NCT03832179Overall official - principal investigatorPhase 4Nov 15, 2018
- NCT03832179Lead sponsorPhase 4Nov 15, 2018
- NCT03817645Overall official - principal investigatorN/AMar 9, 2018
- NCT02751151Overall official - principal investigatorN/AFeb 29, 2016
- NCT02354170Sponsor investigatorPhase 2Jan 1, 2015
- NCT02354170Overall official - principal investigatorPhase 2Jan 1, 2015
- NCT02354170Lead sponsorPhase 2Jan 1, 2015
Details
- Last known activity
- Nov 30, 2023